PORTER Debuts Lightweight "Grocery Bag" for Everyday Essentials
PORTERhas debuted the 'Grocery Bag' offering, exclusive for its newly-openedBusan brick-and-mortar store.
The carrying option stays true to its name, arriving in the shape of an actual grocery bag and optimized for light storage on a regular day. Wrapped in a durable chrome lipstop nylon with an exterior corner pocket, the bag also features hits of deep blue by the interior buttons, strap and insignias — reminiscent of the Busan sea in the summer. Users also have the option to connect the strap to the D-ring, allowing for various wearing styles dependent on personal need.
PORTER 'Grocery Bag'is sold exclusively at PorterBusanfor ₩298,000 KRW (approximately $215 USD) for a limited time.
PORTER KOREA BUSAN3rd Floor, Shinsegae Centum City,35 Centumnam-daero, Haeundae-gu,Busan 48058, South Korea
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
35 minutes ago
- Hamilton Spectator
Cologix Closes $525 Million USD Asset-Backed Securitization to Support AI Infrastructure, Interconnection and Growth
DENVER, July 21, 2025 (GLOBE NEWSWIRE) — Cologix , a leading network-neutral interconnection and hyperscale edge data center company in North America, today announced that it has closed a $525 million USD asset-backed securitization (ABS) to support the company's continued growth in digital infrastructure. The secured notes are backed by Cologix's COL4 data center in Columbus, Ohio, and structured with a five-year fixed term. This transaction marks Cologix's fourth ABS issuance since 2021 and reflects the company's continued use of the asset-backed securities market to fund growth. Proceeds will support strategic investments across Cologix's Scalelogix℠ and Digital Edge portfolio, enabling the company to address increasing demand for inference AI and cloud workloads. 'This transaction demonstrates the strength of our balance sheet, the continued support of our investor base and the market's confidence in our long-term strategy,' said Scott Schneider, Chief Financial Officer of Cologix. 'As we kick off our next wave of growth, this financing will help us scale critical infrastructure to meet the increasing demands of hyperscale and inference AI applications.' Cologix continues to expand its hyperscale edge footprint across North America, helping customers deploy cloud and AI-ready digital infrastructure at the network edge. This latest ABS financing follows three prior transactions in 2021, 2022 and 2023, further supporting the company's ability to scale critical infrastructure with speed and confidence. 'Our ability to deliver scalable, sustainable and deeply connected data center solutions is a key driver of customer success,' said Laura Ortman, Chief Executive Officer of Cologix. 'This financing ensures we're well-positioned to meet the needs of cloud providers, enterprise and AI customers seeking reliable, high-density interconnection at the edge.' Cologix continues to prioritize operational sustainability in its growth strategy, maintaining average Power Usage Effectiveness (PUE) and Water Usage Effectiveness (WUE) rates that significantly outperform industry benchmarks. These efficiency measures reflect the company's commitment to responsible digital infrastructure development while scaling to meet future needs. Deutsche Bank Securities Inc. served as the lead bank on the transaction and legal counsel was provided by King & Spalding. About Cologix Cologix powers digital infrastructure with 45+ hyperscale edge data centers and interconnection hubs across 12 North American markets, providing high-density, ultra-low latency solutions for cloud providers, carriers and enterprises. With AI-ready, industry-leading facilities, Cologix offers scalable, flexible and sustainable data center options to help its customers accelerate their business at the digital edge. Cologix provides extensive physical and virtual connections, including Access Marketplace, where customers gain fast, reliable and self-service provisioning for on-demand connectivity. For more information, visit Cologix or follow us on LinkedIn and X . Media Contact for Cologix: Shifali Erasmus, Crackle PR cologix@ A photo accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
We're about to find out if the crypto market is big enough to raise the price of U.S. bonds and the dollar
President Trump's GENIUS Act legalizes stablecoins and requires them to be backed by U.S. dollars or Treasuries. That's going to increase demand for dollar-backed assets and, maybe, cement the dollar's reserve currency status. Bitcoin and Ether have both risen as a result, alongside a modest recovery in the U.S. dollar. Bitcoin is up. Ether is up. And the dollar is up—a little. These things might be related if you believe, as many in the cryptocurrency world do, that the Trump Administration's regulatory support for crypto will revolutionize digital payments. Bitcoin was up 1.27% this morning at just under $119K per coin. ETH rose sharply by nearly 12% over the last five days. These gains came as President Trump signed the GENIUS Act, which legalizes stablecoins. Stablecoins are cryptocurrencies that maintain their value at 1:1 with fiat currency, usually the U.S. dollar. The GENIUS Act specifically requires that stablecoins in the U.S. be backed by dollars or U.S. Treasuries. That will lock in demand for dollars and short-term U.S. bonds from stablecoin issuers, and that in turn will support both the dollar and the price of bonds. Lo and behold, the U.S. dollar, which had been down by 10.8% year-to-date at the beginning of the month, has picked itself up and is now down only 9.39%. The act 'formalizes stablecoin issuers' role as quasi money market funds, supporting US short-term debt markets and channeling non-USD liquidity into dollars,' Deutsche Bank analysts Marion Laboure and Camilla Siazon told clients in a note seen by Fortune. 'At a time when US dollar hegemony is under question, this has been seen as a win by the Trump administration. On Friday, Trump affirmed that the GENIUS Act would 'secure the dollar's status as the world reserve currency,' and followed that if the US were to lose its reserve status, it would be akin to the US 'losing a world war.'' It's not yet clear whether the crypto market is big enough to push up the price of the dollar. But it might be, Laboure and Siazon say. 'Tether alone holds over ~$120bn in treasury bills as of Q1 2025 and ranks amongst the top holders of US treasuries.' 'The US treasury predicts that T-bills held by stablecoin issuers (excluding interest-bearing stablecoins) will grow to ~$1trn by 2028,' they said. The act also bans stablecoin issuers from offering 'yield' to holders. (In cryptoworld, yield is a stream of payments that looks a lot like interest given to anyone who offers their crypto holdings as a loan to borrowers on a crypto exchange.) Because stablecoins will not be able to offer payments to holders, it looks as if crypto investors are piling into ETH, which has long offered yield payments to anyone willing to 'stake' their coins as a security on the Etherium blockchain. (Staking involves punishing anyone who approves a false transaction on the blockchain but rewarding anyone with new ETH if they approve a true transaction.) 'This perhaps explains why we are also seeing a rise in Ether (+25%) last week, as expectations for diminished stablecoin yields are driving interest towards Ethereum as the primary alternative for yield generation in decentralized finance,' the pair said. Here's a snapshot of the action prior to the opening bell in New York: S&P 500 futures were up 0.24% this morning. The index closed flat at 6,296.79 on Friday. China's Composite was up 0.72%. The STOXX Europe 600 was down 0.17% in early trading. The UK FTSE 100 was down 0.18% in early trading. The Nikkei 225 was down 0.21%. Bitcoin was up 1.27%, at just under $119K. This story was originally featured on Sign in to access your portfolio
Associated Press
6 hours ago
- Associated Press
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, inclusive (the 'Class Period'). Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon as well as certain of Organon's top executives with violations of the Securities Exchange Act of 1934. A previously filed complaint is captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.). If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the Organon class action lawsuit must be filed with the court no later than this upcoming Tuesday, July 22, 2025. CASE ALLEGATIONS: Organon develops and delivers health solutions through prescription therapies and medical devices. The Organon class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Organon faced a higher risk of loss of exclusivity and price erosion as to Nexplanon than implied by its Class Period statements; (ii) as a result, Organon's long-term Nexplanon sales growth was not as strong as defendants' portended during the Class Period, and would not reach $1 billion by the end of fiscal year 2025 (much less upwards of $1.5 billion after that), and that Organon was likely not on track to achieve the $1 billion milestone payment from Merck & Co. on its Nexplanon sales thereafter; (iii) thus, Organon was not on track to achieve, much less maintain, the $1 billion in free cash flow required to sustain its outsized dividend; (iv) consequently, Organon was also not on track to maintain 4.0x debt leverage; (v) as such, Organon might not be able to maintain its corporate debt ratings at their then-current Class Period levels; and (vi) as a result, Organon lacked a reasonable basis to report its Class Period business metrics and financial projections. The Organon class action lawsuit further alleges that on May 1, 2025, in connection with announcing its first quarter 2025 financial results for the interim period ended March 31, 2025, Organon slashed its dividend by 90%, down from 28¢ per share per quarter ($1.16 per share annually) down to just 2¢ per share per quarter (or 8¢ per share annually). According to a quote attributed to Organon's CEO, defendant Kevin Ali, in the press release Organon issued that day, it had 'reset [its] capital allocation priorities to accelerate progress towards deleveraging, enabling a path to achieve a net leverage ratio of below 4.0x by year-end,' emphasizing that Organon's 'primary capital allocation priority' was now 'maintaining lower leverage.' On this news, the price of Organon stock fell more than 27%. The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud. You can view a copy of the complaint by clicking here. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Organon publicly traded securities during the Class Period to seek appointment as lead plaintiff in the Organon class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Organon class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Organon class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Organon class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]
